EGFR and cancer: An elegant work by Bi et al. showed that constitutive activation of epidermal growth factor receptor (EGFR) upregulated lysophosphatidylcholine acyltransferase 1 (LPCAT1) and promoted continuous oncogene activation cancer cells[13] [Table 1].